Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04477759
Title Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer (DEHART)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

hypopharynx cancer

laryngeal squamous cell carcinoma

oral cavity cancer

head and neck squamous cell carcinoma

oropharynx cancer

Therapies

Atezolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.